Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients-Reference-Cited by-同舟云学术

Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients

Published:2021-05-15 Issue:10 Volume:56 Page:2510-2517
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Shimomura Yoshimitsu^ORCID,Hara Masahiko,Konuma Takaaki^ORCID,Itonaga Hidehiro^ORCID,Doki Noriko,Ozawa Yukiyasu,Eto Tetsuya,Uchida Naoyuki^ORCID,Aoki Jun^ORCID,Kato Jun^ORCID,Onishi Yasushi,Takahashi Satoshi,Fukushima Kentaro,Nakamae Hirohisa^ORCID,Kawakita Toshiro,Tanaka Junji,Fukuda Takahiro,Atsuta Yoshiko^ORCID,Ishikawa Takayuki,Ishiyama Ken^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01324-8.pdf

Reference40 articles.

1. Lindsley RC, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, et al. Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation. N. Engl J Med. 2017;376:536–47.

2. de Witte T, Hermans J, Vossen J, Bacigalupo A, Meloni G, Jacobsen N, et al. Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol. 2000;110:620–30.

3. Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, et al. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. Blood. 2002;100:1997–2004.

4. Aoki K, Ishikawa T, Ishiyama K, Aoki J, Itonaga H, Fukuda T, et al. Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study. Br J Haematol. 2015;168:463–6.

5. Park S-S, Jeon Y-W, Min GJ, Park S, Yahng S-A, Yoon J-H, et al. Graft-versus-host disease-free, relapse-free survival after allogeneic stem cell transplantation for myelodysplastic syndrome. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2019;25:63–72.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WT1 gene mutations impact post-transplant relapse in myelodysplastic syndrome with excess blasts 2 patients;Annals of Hematology;2024-07-06

2. Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy;Bone Marrow Transplantation;2024-05-07

3. Comparison of Melphalan Dose in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Transplantation with Reduced-Intensity Conditioning;Transplantation and Cellular Therapy;2024-05

4. Validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic neoplasms (MDS) and comparison with the revised International Prognostic Scoring System (IPSS-R) in Chinese Population: A Multicenter Retrospective Study.;2024-03-25

5. Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: A nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy;2023-12-21